Risk of benign gynaecological disease and hormonal disorders according to responsiveness to ovarian stimulation in IVF: A follow-up study of 8714 women

Human Reproduction

Volumn 18, Issue 9, 2003, Pages 1951-1958

  Klip, H ^a,b   Van Leeuwen, F E ^b   Schats, R ^c   Burger, C W ^d   Kortman, M ^e   Te Velde, E R ^e   Macklon, N ^d   Jansen, C A M ^f   Leerentveld, R A ^a   Willemsen, W N P ^g   Naaktgeboren, N ^h   Helmerhorst, F M ^h   Bots, R S G M ⁱ   Simons, A H M ^j   Hogerzeil, H V ^k   Evers, J L H ^l   Van Dop, P A ^m  

^a Research Bureau   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f Diaconessenhuis   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ CPRLab   (Netherlands)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^m CATHARINA HOSPITAL   (Netherlands)

more..

Author keywords

IVF; Long term follow up; OHSS; Ovarian cysts; Uterine leiomyoma

Indexed keywords

FERTILITY PROMOTING AGENT; GONADOTROPIN DERIVATIVE; ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; ENDOCRINE DISEASE; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; GYNECOLOGIC DISEASE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MEDICAL RECORD; ONSET AGE; OOCYTE; OVARY CYST; OVARY DISEASE; OVULATION INDUCTION; PELVIC INFLAMMATORY DISEASE; QUESTIONNAIRE; RISK ASSESSMENT; SELF REPORT; SUBFERTILITY; THYROID DISEASE; UTERUS MYOMA;

EID: 10744227710     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg358     Document Type: Article

References (30)

1. Abulafia, O. and Sherer, D.M. (2000) Angiogenesis of the ovary. Am. J. Obstet. Gynecol., 182, 240-246.
2. Braga, C., Negri, E., La Vecchia, C., Parazzini, F., Dal Maso, L. and Franceschi, S. (1996) Fertility treatment and risk of breast cancer. Hum. Reprod., 11, 300-303.
3. Chen, C.R., Buck, G.M., Courey, N.G., Perez, K.M. and Wactawski-Wende, J. (2001) Risk factors for uterine fibroids among women undergoing tubal sterilization. Am. J. Epidemiol., 153, 20-26.
4. Cox, D.R. (1972) Regression models and life tables. J. R. Statist. Soc. Ser. B, 334, 187-202.
5. Davis, O.K. and Rosenwaks, Z. (1995) In vitro fertilization. In Keye, W.R., Chang, R.J., Rebar, R.W. et al. (eds), Infertility: Evaluation and Treatment. W.B. Saunders Co., Philadelphia, pp. 759-771.
6. DeBoer, E.J., Ten Tonkelaar, I., Te Velde, E.G., Burger, C.W., Klip, H. and Van Leeuwen, F.E. (2002) Low number of retrieved oocytes at IVF treatment is predictive of early menopause. Fertil. Steril., 77, 978-985.
7. Fauser, B.C., Devroey, P., Yen, S.S., Gosden, R., Crowley, W.F. Jr., Baird, D.T. and Bouchard, P. (1999) Minimal ovarian stimulation for IVF: Appraisal of potential benefits and drawbacks. Hum. Reprod., 14, 2681-2686.
8. Harris, R., Whittemore, A.S. and Itnyre, J. (1992) Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am. J. Epidemiol., 136, 1204-1211.
9. Kelsey, J.L., Gammon, M.D. and John, E.M. (1993) Reproductive factors and breast cancer. Epidemiol. Rev., 15, 36-47.
10. Klip, H., Burger, C.W., Kenemans, P. and Van Leeuwen, F.E. (2000) Cancer risk associated with subfertility and ovulation induction: A review. Cancer Causes Control, 11, 319-344.
11. Lashen, H., Ledger, W., Lopez-Bernal, A. and Barlow, D. (1999) Poor responders to ovulation induction: Is proceeding to in-vitro fertilization worthwhile? Hum. Reprod., 14, 964-969.
12. Modan, B., Ron, E., Lerner-Geva, L., Blumstein, T., Menczer, J., Rabinovici, J., Oelsner, G., Freedman, L., Mashiach, S. and Lunenfeld, B. (1998) Cancer incidence in a cohort of infertile women. Am. J. Epidemiol., 147, 1038-1042.
13. Mosgaard, B.J., Lidegaard, O., Kjaer, S.K., Schou, G. and Andersen, A.N. (1997) Infertility, fertility drugs and invasive ovarian cancer: A case-control study. Fertil. Steril., 67, 1005-1012.
14. Navot, D. and Bergh, P.A. (1993) Ovarian hyperstimulation syndrome: A practical approach. Amsterdam, The Netherlands. Proceedings of the 8th Reinier de Graaf Symposium.
15. Parazzini, F., Negri, E., La Vecchia, C., Moroni, S., Franceschi, S. and Crosignani, P.G. (1997) Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum. Reprod., 12, 2159-2161.
16. Parazzini, F., Negri, E., La Vecchia, C., Moroni, S., Polatti, A., Chiaffarino, F., Surace, M. and Ricci, E. (1998) Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol. Oncol., 68, 226-228.
17. Parazzini, F., Pelucchi, C., Negri, E., Franceschi, S., Talamini, R., Montella, M. and La Vecchia, C. (2001) Use of fertility drugs and risk of ovarian cancer. Hum. Reprod., 16, 1372-1375.
18. Potashnik, G., Lerner-Geva, L., Genkin, L., Chetrit, A., Lunenfeld, E. and Porath, A. (1999) Fertility drugs and the risk of breast and ovarian cancers: Results of a long-term follow-up study. Fertil. Steril., 71, 853-859.
19. Ron, E., Lunenfeld, B., Menczer, J., Blumstein, T., Katz, L., Oelsner, G. and Serr, D. (1987) Cancer incidence in a cohort of infertile women. Am. J. Epidemiol., 125, 780-790.
20. Rossing, M.A., Daling, J.R., Weiss, N.S., Moore, D.E. and Self, S.G. (1994) Ovarian tumors in a cohort of infertile women. N. Engl. J. Med., 331, 771-776.
21. Rossing, M.A., Daling, J.R., Weiss, N.S., Moore, D.E. and Self, S.G. (1996) Risk of breast cancer in a cohort in infertile women. Gynecol. Oncol., 60, 3-7.
22. Rothman, K.J. and Greenland, S. (1998) Modern Epidemiology. Lippincot-Raven, Philadelphia.
23. Schwartz, S.M. (2001) Invited commentary: Studying the epidemiology of uterine leiomyomata - Past, present and future. Am. J. Epidemiol., 153, 27-29.
24. Shu, X.O., Brinton, L.A., Gao, Y.T. and Yuan, J.M. (1989) Population-based case-control study of ovarian cancer in Shanghai. Cancer Res., 49, 3670-3674.
25. Shushan, A., Paltiel, O., Iscovich, J., Elchalal, U., Peretz,T. and Shenker, J.G. (1996) Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil. Steril., 65, 13-18.
26. Simons, A.H.M. (ed.) (1998) NVOG-richtlijn: Het ovarieel hyperstimulatiesyndroom. [Dutch]. Nederlandse Vereniging voor Obstetrie en Gynaecologie, Utrecht, 11, 1-8.
27. Surrey, E.S. (1995) Hyperstimulation syndrome. In: Keye, W.R., Chang, R.J., Rebar, R.W. et al. (eds), Infertility: Evaluation and Treatment. W.B. Saunders Co., Philadelphia, pp. 145-153.
28. Venn, A., Watson, L., Lumley, J., Giles, G., King, C. and Healy, D. (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet, 346, 995-1000.
29. Venn, A., Watson, L., Bruinsma, F., Giles, G. and Healy, D. (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet, 354, 1586-1590.
30. Whittemore, A.S., Harris, R. and Itnyre, J. (1992) Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am. J. Epidemiol., 136, 1184-1203.